Status:
COMPLETED
Interrupting Prolonged Sitting With ACTivity (InPACT) at Home Optimization Study
Lead Sponsor:
University of Michigan
Conditions:
Adherence, Treatment
Physical Inactivity
Eligibility:
All Genders
8-12 years
Phase:
NA
Brief Summary
Adherence refers to how well a person follows a recommended and agreed-upon course of action. Adherence is necessary for desired clinical outcomes and can include attending appointments, making lifest...
Detailed Description
Experimental protocol: In Stage 1 of the intervention, 30 child participants will enroll in a home exercise program called InPACT at Home. The objective is for each participant to complete three 8-min...
Eligibility Criteria
Inclusion
- This study will include both males and females aged 8 to 12 years and their parent/guardian from various locations in Michigan. The investigators have chosen this age group because this is a critical age with physical activity participation declines (75% from the age of 9 to 15 years). To be included in the study, participants must:
- Have access to a computer and internet at home.
- Be proficient in English.
Exclusion
- Children will not be eligible for the study if they meet any of the following conditions:
- Currently taking medications (e.g., iron, metformin, chemotherapeutic agents) that could impact their ability to engage in physical activity.
- Previously diagnosed with conditions that could impact their ability to engage in physical exercise (e.g., uncontrolled asthma).
- Answering "YES" to any question on the Physical Activity Readiness Questionnaire (PAR-Q)22 indicating the participant has a heart condition, high BP, experienced chest pains or dizziness during daily activities, or require a doctor's recommendation for supervision during exercise.
- Diagnosed with a physical or mental disability that would make it difficult to answer questions or follow directions without the help of an adult.
- Parent or caregiver has a physical or mental disability that would make it difficult for them to answer questions or assist their child with project-related activities, such as completing questionnaires in the laboratory.
- Potential participants who are ineligible will be told so on their screening call and will not be enrolled.
Key Trial Info
Start Date :
August 20 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 15 2025
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT06493214
Start Date
August 20 2024
End Date
July 15 2025
Last Update
November 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Michigan
Ann Arbor, Michigan, United States, 48109